The answer appears in a study published in the current issue of the Proceedings of the National Academy of Sciences, U.S.A., Drs. Haining Yang and Michele Carbone at the University of Hawai'i Cancer Research Center led a research team that included collaborators at New York University, University of Chicago, University of Pittsburgh, San Raffaele University of Milano, and the Imperial College in London.
These researchers addressed the paradox of how asbestos fibers that kill cells could cause cancer, since a dead cell should not be able to grow and form a tumor. They found that when asbestos kills cells, it does so by inducing a process called "programmed cell necrosis" that leads to the release of a molecule called high-mobility group box 1 protein (HMGB1). HMGB1 starts a particular type of inflammatory reaction that causes the release of mutagens and factors that promote tumor growth. The researchers found that patients exposed to asbestos have elevated levels of HMGB1 in their serum. Therefore, they state that it may be possible to target HMGB1 to prevent or treat mesothelioma and identify asbestos-exposed cohorts by simple HMGB1 serological testing.
In the article, the researchers propose that by interfering with the inflammatory reaction caused by asbestos and HMGB1, it may be possible to decrease cancer incidence among cohorts exposed to asbestos and decrease the rate of tumor growth among those already affected by mesothelioma. Drs. Yang and Carbone, the lead authors, state that to test this hypothesis, they are now planning a clinical trial in a remote area in Cappadocia, Turkey, where over 50% of the population dies of malignant mesothelioma. If the results are positive, the approach will be extended to cohorts of asbestos-exposed individuals in the U.S.
This research emphasizes the role of inflammation in causing different types of cancers and provides novel clinical tools to identify exposed individuals and prevent or decrease tumor growth. The researchers question if it will be possible to prevent mesothelioma, like colon cancer, simply by taking aspirin or similar drugs that stop inflammation. They are about to test this hypothesis.
The article is authored by Haining Yang, Zeyana Rivera, Sandro Jube, Masaki Nasu, Pietro Bertino and Michele Carbone at the University of Hawai'i Cancer Research Center; Harvey I. Pass and Chandra Goparaju at New York University; Thomas Krausz at the University of Chicago; Michael T. Lotze at the University of Pittsburgh; Guido Franzoso at the Imperial College of London, U.K.; and Marco E. Bianchi at the University of San Raffele Milano, Italy. It will be published online in the Proceedings of the National Academy of Sciences U.S.A. the week of June 28 2010, and later in print. The study was supported by grants from the U.S. National Cancer Institute, and by the Mesothelioma Applied Research Foundation.
Email or share this story:|MoreStory Source:
The above story is reprinted (with editorial adaptations by ScienceDaily staff) from materials provided by University of Hawaii at Manoa.Journal Reference:
Haining Yang, Zeyana Rivera, Sandro Jube, Masaki Nasu, Pietro Bertino, Chandra Goparaju, Guido Franzoso, Michael T. Lotze, Thomas Krausz, Harvey I. Pass, Marco E. Bianchi, and Michele Carbone. Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation. Proceedings of the National Academy of Sciences, 2010; DOI: 10.1073/pnas.1006542107Need to cite this story in your essay, paper, or report? Use one of the following formats: APAMLA
Note: If no author is given, the source is cited instead.
Related StoriesElevated Blood Levels Of A Protein Are Linked To Asbestos-Induced Cancers (Oct. 17, 2005) — Researchers at New York University School of Medicine and Wayne State University have found a molecule that reveals the early stages of pleural mesothelioma, a chest cancer caused by asbestos. The ... > read moreHow Asbestos Fibers Trigger Cancer In Human Cells (Dec. 22, 2008) — Scientists are now studying the molecular underpinnings of cancer by probing individual bonds between an asbestos fiber and human cells. Though any clinical application is years away, the researchers ... > read moreNaturally Occurring Asbestos Linked To Lung Cancer (July 15, 2005) — Everyday exposure to naturally occurring asbestos increases the risk of developing malignant mesothelioma, according to a study by UC Davis researchers. The study - the largest to examine the ... > read moreAsbestos Disease Projections Too Low (Apr. 4, 2007) — Current predictions of the future incidence of asbestos-related disease have been substantially underestimated, according to new modelling to be presented in Melbourne today by an epidemiologist from ... > read moreMesothelioma: Chemo Combination Improves Survival In Asbestos-Related Cancer (Feb. 11, 2007) — People with mesothelioma -- a form of cancer associated with asbestos exposure -- have a higher survival rate when treated with a combination of two cancer drugs, a large multicenter study ... > read moreSearch ScienceDailyNumber of stories in archives: 87,968Find with keyword(s): Enter a keyword or phrase to search ScienceDaily's archives for related news topics,the latest news stories, reference articles, science videos, images, and books.
Just In:N. America's First Peoples More Diverse?Gene Leads to Longer Shelf Life for TomatoesCompetition Matters in Disturbed EcosystemsWhiter Clouds Could Mean Wetter LandGlimpse at Earliest Phases of Milky WayProgrammable Matter Folding Like OrigamiLarger-Than-Average Gulf 'Dead Zone' PredictedWorld First for Quantum Memory Storage Science Video News
Surviving Lung CancerIn a new procedure, called thorascopic lobectomy, surgeons make three small incisions in the chest and use specially designed instruments to reach. ... > full storyCancer Biologists Develop More Accurate Blood Test for Prostate CancerPaleontologists Teach Medical Students About Fossil TumorsPhysicists Develop Ultrasound Alternative To Mammogramsmore science videos 
Copyright © 1995-2010 ScienceDaily LLC — All rights reserved — Contact: editor@sciencedaily.com
Part of the iVillage Your Total Health Network
0 comments:
Post a Comment